Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10
Introduction
00:00 • 2min
The Loss of Immuno Oncology Targets
01:59 • 2min
The Role of Metabolic Targets in Cancer Research
03:47 • 2min
The Emergence of the PRMT Five Inhibitors
06:03 • 2min
KRS: A 30 Year Overnight Success Story
08:30 • 2min
ABC Trials Outnumber New Maps
10:18 • 3min
The Merck and Moderna Neo Antigen Cancer Vaccine Combo
12:58 • 2min
The Importance of a Checkpoint Inhibitor in Immunotherapy
15:12 • 2min
The Role of Antigens in Cancer Neo Antigen Vaccines
17:16 • 2min
The Impact of the Commercial Model for a Personalized Cancer Vaccine
19:07 • 3min